Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 2
1982 7
1983 5
1984 6
1985 12
1986 14
1987 10
1988 16
1989 15
1990 16
1991 23
1992 12
1993 26
1994 17
1995 22
1996 19
1997 20
1998 31
1999 18
2000 44
2001 51
2002 74
2003 87
2004 91
2005 161
2006 212
2007 203
2008 230
2009 276
2010 341
2011 427
2012 415
2013 489
2014 612
2015 738
2016 807
2017 819
2018 929
2019 1083
2020 1327
2021 727
Text availability
Article attribute
Article type
Publication date

Search Results

9,380 results
Results by year
Filters applied: . Clear all
Page 1
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
Sekeres MA, Watts J, Radinoff A, Sangerman MA, Cerrano M, Lopez PF, Zeidner JF, Campelo MD, Graux C, Liesveld J, Selleslag D, Tzvetkov N, Fram RJ, Zhao D, Bell J, Friedlander S, Faller DV, Adès L. Sekeres MA, et al. Among authors: zhao d. Leukemia. 2021 Jan 22. doi: 10.1038/s41375-021-01125-4. Online ahead of print. Leukemia. 2021. PMID: 33483617 No abstract available.
Regulator Network Analysis of Rice and Maize Yield-Related Genes.
Chen Z, Shen Z, Xu L, Zhao D, Zou Q. Chen Z, et al. Among authors: zhao d. Front Cell Dev Biol. 2020 Dec 3;8:621464. doi: 10.3389/fcell.2020.621464. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33425929 Free PMC article.
Engineered nanomedicines for tumor vasculature blockade therapy.
Zhao D, Huang X, Zhang Z, Ding J, Cui Y, Chen X. Zhao D, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 May;13(3):e1691. doi: 10.1002/wnan.1691. Epub 2021 Jan 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 33480163 Review.
9,380 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page